{"disease":{"id":"lysosomal-storage-diseases","name":"lysosomal storage diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04393701","title":"A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry","phase":"NA","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT02416661","title":"Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease","phase":"","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT04943991","title":"Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT03893240","title":"Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04399694","title":"Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06130228","title":"Nutritional Therapy in Late-onset Pompe Disease","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT03853876","title":"A Natural History Study of Aspartylglucosaminuria","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Neurogene Inc.","has_results":false},{"nct_id":"NCT04283227","title":"OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT03897361","title":"Stem Cell Gene Therapy for Cystinosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT04040049","title":"A Fabry Disease Gene Therapy Study","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Spur Therapeutics","has_results":false},{"nct_id":"NCT04455230","title":"A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Spur Therapeutics","has_results":false},{"nct_id":"NCT02363153","title":"Diet and Exercise in Pompe Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT01963650","title":"Natural History Study of Children With Metachromatic Leukodystrophy","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT04189601","title":"Complement Activation in the Lysosomal Storage Disorders","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Melbourne Health","has_results":false},{"nct_id":"NCT01458613","title":"Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}